Hypoglycemia at the time of Covid-19 pandemic

Diabetes & Metabolic Syndrome
Kiran ShahAlpana Sowani

Abstract

Hypoglycemia is the limiting factor in the glycemic management of diabetes, which need to be addressed critically to avoid complications. Lockdown because of new coronavirus strain (COVID-19) pandemic has further complicated the issue of hypoglycemia due to limitations in access to food, outpatient clinics, pathological services and medicines. To assess the factors associated with the risk of hypoglycemia during April-May 2020 lockdown in people with type 2 diabetes mellitus. We analyzed the data retrospectively from 146 patients of type 2 diabetes mellitus (T2DM) reporting to the emergency department (ED) during lockdown period with symptoms suggestive of hypoglycemia. The majority of patients were male (90/146) with a mean age of 59.88 ± 10.09 years and a mean random blood glucose level of 57.67 ± 9.00 mg/dL. Two-third of patients (70.83%) had level 1 hypoglycemia, while level 2 hypoglycemia was reported in 29.16% of patients. A combination of Metformin and Sulfonylureas (SU) was most commonly associated with the risk of hypoglycemia (65.75%) followed by insulin (33.56%). Subjects who received insulin reported a lower blood glucose value (50.75 ± 8.20 mg/dL) as compared to those receiving a combination of metformin and SU (60...Continue Reading

Citations

Jun 4, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·J CalvãoJ C Cardoso
May 3, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·N Kluger, J N Scrivener
May 7, 2021·Therapeutics and Clinical Risk Management·Sultan A M SaghirMohamed E Abd El-Hack
Jun 2, 2021·Diabetes Technology & Therapeutics·Satish K Garg, Trenton Reinicke
May 21, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Shuang HuaDewei Ye
Jun 8, 2021·Expert Review of Endocrinology & Metabolism·Aman RajpalDavid C Aron

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.